On August 5, 2026, Alto Ingredients, Inc. entered into an At-The-Market Issuance Sales Agreement with Craig-Hallum Capital Group LLC and other agents to offer up to $50.0 million of its common stock. The company intends to use net proceeds for general corporate purposes, including working capital and capital expenditures. Agents will receive a 3.0% commission on gross proceeds. This filing relates to Alto Ingredients, Inc., which operates in the specialty chemicals industry by producing renewable ingredients from agricultural commodities.

Alto Ingredients, Inc. reported second quarter 2026 financial results for the period ended June 30, 2026. Net sales increased to $245.7 million from $218.4 million in the prior year period. The company achieved a gross profit of $16.6 million and net income attributable to common stockholders of $11.4 million, or $0.15 per diluted share, compared to a net loss of $11.3 million previously. Adjusted EBITDA improved to $23.7 million from negative $0.2 million. Management also announced the establishment of a new $50 million at-the-market equity program to provide financial flexibility for future opportunities.

On June 23, 2026, stockholders approved the 2026 Omnibus Incentive Plan, which allows for the issuance of up to 7,000,000 shares of common stock as equity and equity-based awards to officers, directors, employees, and consultants. The plan will remain in effect until June 23, 2036. Additionally, stockholders elected five directors, approved 2025 executive compensation, and ratified RSM US LLP as the independent registered public accounting firm for the year ending December 31, 2026. The company operates in the agricultural chemicals and biofuels industry, producing ethanol and other specialty ingredients.